跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AFLURIA TETRA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AFLURIA TETRA
Authorized
STANDARD
AFLURIA TETRA
SEQIRUS PTY LTD
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
af11603ecdc0905f
Company
SEQIRUS PTY LTD
Type
Standard
Approval Details
Approval Id
af11603ecdc0905f
Drug Approval Canada Name
AFLURIA TETRA
Product Name
AFLURIA TETRA
Status
Marketed
Status Date
2020-09-23
Original Market Date
2020-09-23
Din
02473313
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Atc Name
j 07 bb 02
Aig Number
0455410003
Company Name
SEQIRUS PTY LTD
Company Address
63 Poplar Road, Parkville, Victoria, Australia, 3052
Company Detail Path
/organization/seqirus-pty-ltd
Company Information
Pharmaceutical Company Name
SEQIRUS PTY LTD
Country Name
Australia
Province Name
Victoria
City Name
parkville,victoria,country_au
Address
63 Poplar Rd
Active Ingredients
HAEMAGGLUTININ-STRAIN A (H1N1)
15 MCG / 0.5 ML
HAEMAGGLUTININ-STRAIN A (H3N2)
15 MCG / 0.5 ML
HAEMAGGLUTININ-STRAIN B (VICTORIA)
15 MCG / 0.5 ML
HAEMAGGLUTININ-STRAIN B (YAMAGATA)
15 MCG / 0.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
af11603ecdc0905f
Type
Standard
Back to Health Canada Approvals